期刊文献+

老年2型糖尿病患者血清炎症因子水平及其与大血管病变的相关性 被引量:3

暂未订购
导出
摘要 目的观察2型糖尿病患者血清炎症因子水平的变化,探讨炎症因子对2型糖尿病尤其老年患者合并心脑血管病变的影响。方法103例2型糖尿病患者按年龄及是否合并心脑血管病变分别分组。测定所有患者血清高敏C反应蛋白(hsC—RP)、FBG、HbA,c.TC、TG、LDL—C水平,用ELISA方法测定血清白介素6(IL-6)和肿瘤坏死因子a(TNF—Q)水平。结果①2型糖尿病患者年龄≥65岁者,血清hsC—RP、TNF—α、IL-6水平均高于年龄〈65岁者(P〈0.01)。②合并心脑血管病变者,血清hsGRP水平较高于无心脑血管病变者(P〈0.05)。年龄≥65岁中合并心脑血管病变者,血清hsC-RP水平高于无心脑血管病变者(P〈0.05)。③血清hsC—RP水平与年龄和血清TG水平呈正相关(r=O.257,P〈0.01;r=0.220,P〈0.01)。影响hsC—RP的因素主要为年龄,回归方程为y(hsC—RP)=2.407+0.100年龄。④2型糖尿病中≥65岁者合并心脑血管病变的发生率高于〈65岁者(P〈0.01)。结论hsC—RP与大血管病变相关,但IL-6和TNF—n与大血管病变无明显相关性;年龄增长是血清hsC—RP水平升高的主要影响因素。
出处 《医学信息》 2012年第8期121-122,共2页 Journal of Medical Information
  • 相关文献

参考文献2

二级参考文献11

  • 1Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,33:309-315.
  • 2Stern MP. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes, 1995,44:369-374.
  • 3Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes, 2001,50:2384-2388.
  • 4Verma S, Li SH, Badiwada MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 2002,105:1890-1896.
  • 5Dandona P, Aliada A. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and athelosclerosis. Am J Cardiol, 2002,90:27G-33G.
  • 6UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macmvascular and micmvascular complication in type 2 diabetes, UKPDS 38[J]. BMJ, 1998, 317: 703-713.
  • 7Rizos E, Mikhailidis DP. Are high-density lipoprotein and triglyceride levels important in secondary prevention: impressions from the BIP and VA-HIT trials[J]. Int J Cardiol, 2002, 82: 199-208.
  • 8Schaper NC. Early atherogenesis in diabetes mellitus[J]. Diabet Med,1996, 13:S23.
  • 9Deckert T. Nephropathy and coronary death : the fatal twins in diabetes mellitus[J]. Nephrol Dial Transplant, 1994, 9: 1069.
  • 10周玉芳,吴晓光,汤哲,刘向红,贾健.老年人常见病调查与随访分析[J].中华老年医学杂志,1997,16(1):49-52. 被引量:47

共引文献88

同被引文献22

  • 1Koska J,Saremi A,Bahn G,et al.The effect of intensive glucose lowering on lipoprotein particle profiles and inflammatory markers in the Veterans Affairs Diabetes Trial(VADT)[J].Diabetes Care,2013,36(8):2408-2414.
  • 2Lowe G,Woodward M,Hillis G,et al.Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors:the ADVANCE study[J].Diabetes,2014,63(3):1115-1123.
  • 3Zhou C,Pridgen B,King N,et al.Hyperglycemic Ins2Akita Ldlr-mice show severely elevated lipid levels and increased atherosclerosis:a model of type 1 diabetic macrovascular disease[J].J Lipid Res,2011,52(8):1483-1493.
  • 4Sun WL,Chen LL,Zhang SZ,et al.Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis[J].Arch Oral Biol,2010,55(12):970-974.
  • 5Wu W,Wang M,Sun Z,et al.The predictive value of TNF-αand IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes[J].Acta Diabetol,2012,49(1):3-7.
  • 6Zeng C1,Shi X,Zhang B,et al.The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes:relationship with metabolic factors and complications[J].J Mol Med(Berl),2012,90(2):175-86.
  • 7刘汉庆.中西医结合治疗糖尿病肢体动脉硬化性闭塞症35例[J].安徽中医学院学报,2009,28(1):21-22. 被引量:1
  • 8李永霞,封启明.糖尿病患者阿司匹林抵抗研究进展[J].海南医学,2010,21(10):115-117. 被引量:1
  • 9李雪宏,卢秀兰,黄海燕,张淑贞.糖调节受损者炎症细胞因子表达与心电图异常的关系[J].中国心血管病研究,2010,8(10):736-739. 被引量:1
  • 10王利娜,方朝晖.炎症因子与糖尿病大血管动脉粥样硬化探讨[J].中医药临床杂志,2011,23(2):108-110. 被引量:6

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部